(Q39876681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Flavia Foca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Giovanni Brigliadori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Monia Dall'Agata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Claudia Rengucci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Elisabetta Melegari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Serenella Cerasoli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Dino Amadori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Marina Faedi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

publication date

30 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

31 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

333-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Role of MIB1 in predicting survival in patients with glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Glioma extent of resection and its impact on patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

An extent of resection threshold for newly diagnosed glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

MGMT testing--the challenges for biomarker-based glioma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Genome-wide methylation analyses in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Analysis of promoter CpG island hypermethylation in cancer: location, location, location!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2116-Y

Detection of MGMT promoter methylation in glioblastoma using pyrosequencing

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27029617

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27029617

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MGMT promoter methylation and glioblastoma: a comparison of analytical methods and of tumor specimens

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27029617

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-016-2116-Y

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27029617%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference